Healthcare industries: a world of opportunities?

Boxes of Pfizer's Covid-19 tablets in a laboratory in Freiburg (Germany), an image provided to AFP by the pharmaceutical company, November 16, 2021. (Illustrative image) Handout Pfizer/AFP

By: Bruno Faure Follow

2 mins

With the Covid-19 pandemic, big pharma like Pfizer/BioNTech and Moderna hit the jackpot: pre-tax profits of $34 billion last year (2021), or $1,000 per second, according to the report. NGO People's Vaccine Alliance.

And they are not the only ones to profit economically from the health crisis.

Many companies benefit from new markets, which illustrate the general concern of the inhabitants of the planet for their health. 

Advertising

What are the industrial recipes for this success?

What are the challenges for States negotiating contracts?

What place should be given to innovation and how should it be financed?

Where is Africa lagging behind in the development of these pharmaceutical industries? 

OUR GUEST: 

-

health economist, lecturer at the University of Paris 13. 

OUR REPORTS:

- In France, companies are doing well. This is the case of Biosynex, in Alsace in the east of France.

It manufactures tests against the Covid, and its turnover has exploded.

Its CEO Larry Abensur answers questions from Alexis Bédu, from RFI's economy department. 

Biosynex maintenance

BIOSYNEX MAINTENANCE

- Innovation is at the heart of the health sector which, for the first time, had its space reserved for CES in Las Vegas, the major Tech trade show held each year.

How to fight against the virus?

How to live with?

Loïc Pialat, our correspondent, met some imaginative start-ups. 

Las Vegas report

LAS VEGAS REPORT

- Africa is trying to catch up.

In Tunisia, thanks to a pool of doctors and engineers, a wind of innovation is blowing.

Our correspondent Amira Souilem met two entrepreneurs at the head of Innodeep, a start-up that uses artificial intelligence for medicine. 

Report Tunisia Innodeep 

REPORT TUNISIA INNODEEP

OUR BIG INTERVIEW: 

Frédéric Mazzella is the founding president of BlaBlaCar, one of the 26 French unicorns, these start-ups in new technologies whose valuation reaches at least one billion dollars.

His company created in 2006 has democratized carpooling.

It claims 100 million users worldwide.

Frédéric Mazzella publishes a book “ 

 ” (Éyrolles editions).

He recounts his personal experience and reveals the secrets of his success in the innovation sector. 

Interview with Frederic Mazzella, founder of BlaBlaCar

INTERVIEW WITH FREDERIC MAZZELLA, FOUNDER OF BLABLACAR

“Mission Blablacar, behind the scenes of the creation of a phenomenon”, by Frédéric Mazzella.

© Editions Eyrolles

Find us on:

-

-

Newsletter

Receive all the international news directly in your mailbox

I subscribe

Follow all the international news by downloading the RFI application

google-play-badge_FR

• Economy

• Health and medicine

• Vaccines

• Industry

On the same subject

Today the economy, the portrait

Albert Bourla, the boss of Pfizer, CEO of the year 2021 according to CNN business

Covid-19: Pfizer will invest 520 million euros in France

Covid-19: the United States authorizes a Pfizer pill, the United Kingdom exceeds 100,000 cases in 24 hours